H 2 T-Active Injection is a parenteral formulation containing a combination of Folic Acid (0.7 mg), Methylcobalamin (1500 mcg), and Niacinamide (12 mg), designed to address various nutritional deficiencies and support neurological health. Folic Acid, a vital B-vitamin, plays a crucial role in DNA synthesis, red blood cell formation, and prevention of megaloblastic anemia. Methylcobalamin, the active form of Vitamin B12, is essential for maintaining normal nerve function, promoting myelin sheath regeneration, and aiding in the treatment of peripheral neuropathies and vitamin B12 deficiency states. Niacinamide, a form of Vitamin B3, contributes to cellular energy production and exhibits anti-inflammatory properties, which may benefit patients with pellagra or other niacin deficiencies. The synergistic effect of these vitamins in H 2 T-Active Injection facilitates rapid correction of deficiencies, supports hematopoiesis, and enhances neurological recovery. This injection is indicated in cases of anemia due to folate and B12 deficiency, neuropathic conditions, and as adjunct therapy in malabsorption syndromes or chronic alcoholism. Administered intramuscularly or intravenously under medical supervision, H 2 T-Active Injection ensures prompt bioavailability and efficacy. Caution is advised in patients with hypersensitivity to any component, and dosage adjustments may be necessary based on clinical response and laboratory parameters.